Tosti G - Search Results

1

Prognostic significance of hematological profiles in melanoma patients.

Gandini S, Ferrucci PF, Botteri E, Tosti G, Barberis M, Pala L, Battaglia A, Clerici A, Spadola G, Cocorocchio E, Martinoli C. Gandini S, et al. Among authors: tosti g. Int J Cancer. 2016 Oct 1;139(7):1618-25. doi: 10.1002/ijc.30215. Epub 2016 Jun 15. Int J Cancer. 2016. PMID: 27252119 Free article.

2

Oncophage: step to the future for vaccine therapy in melanoma.

di Pietro A, Tosti G, Ferrucci PF, Testori A. di Pietro A, et al. Among authors: tosti g. Expert Opin Biol Ther. 2008 Dec;8(12):1973-84. doi: 10.1517/14712590802517970. Expert Opin Biol Ther. 2008. PMID: 18990084 Review.

3

A phase I-II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma.

Rocca A, Minucci S, Tosti G, Croci D, Contegno F, Ballarini M, Nolè F, Munzone E, Salmaggi A, Goldhirsch A, Pelicci PG, Testori A. Rocca A, et al. Among authors: tosti g. Br J Cancer. 2009 Jan 13;100(1):28-36. doi: 10.1038/sj.bjc.6604817. Br J Cancer. 2009. PMID: 19127265 Free PMC article. Clinical Trial.

4

HSPPC-96 vaccine in metastatic melanoma patients: from the state of the art to a possible future.

Tosti G, di Pietro A, Ferrucci PF, Testori A. Tosti G, et al. Expert Rev Vaccines. 2009 Nov;8(11):1513-26. doi: 10.1586/erv.09.108. Expert Rev Vaccines. 2009. PMID: 19863242 Review.

5

Pelvic sentinel lymph node biopsy in melanoma patients: is it worthwhile?

Soteldo J, Ratto EL, Gandini S, Trifirò G, Mazzarol G, Tosti G, Rastrelli M, Verrecchia F, Baldini F, Testori A. Soteldo J, et al. Among authors: tosti g. Melanoma Res. 2010 Apr;20(2):133-7. doi: 10.1097/CMR.0b013e3283324e40. Melanoma Res. 2010. PMID: 20087232

6

Electrochemotherapy for cutaneous and subcutaneous tumor lesions: a novel therapeutic approach.

Testori A, Tosti G, Martinoli C, Spadola G, Cataldo F, Verrecchia F, Baldini F, Mosconi M, Soteldo J, Tedeschi I, Passoni C, Pari C, Di Pietro A, Ferrucci PF. Testori A, et al. Among authors: tosti g. Dermatol Ther. 2010 Nov-Dec;23(6):651-61. doi: 10.1111/j.1529-8019.2010.01370.x. Dermatol Ther. 2010. PMID: 21054709 Review.

7

The immunological era in melanoma treatment: new challenges for heat shock protein-based vaccine in the advanced disease.

di Pietro A, Tosti G, Ferrucci PF, Testori A. di Pietro A, et al. Among authors: tosti g. Expert Opin Biol Ther. 2011 Oct;11(10):1395-407. doi: 10.1517/14712598.2011.605353. Epub 2011 Jul 30. Expert Opin Biol Ther. 2011. PMID: 21801084 Review.

8

Newly identified tumor antigens as promising cancer vaccine targets for malignant melanoma treatment.

Ferrucci PF, Tosti G, di Pietro A, Passoni C, Pari C, Tedeschi I, Cataldo F, Martinoli C, Testori A. Ferrucci PF, et al. Among authors: tosti g. Curr Top Med Chem. 2012;12(1):11-31. doi: 10.2174/156802612798919213. Curr Top Med Chem. 2012. PMID: 22196269 Review.

9

Sarcoma spreads primarily through the vascular system: are there biomarkers associated with vascular spread?

Pennacchioli E, Tosti G, Barberis M, De Pas TM, Verrecchia F, Menicanti C, Testori A, Mazzarol G. Pennacchioli E, et al. Among authors: tosti g. Clin Exp Metastasis. 2012 Oct;29(7):757-73. doi: 10.1007/s10585-012-9502-4. Epub 2012 Jun 15. Clin Exp Metastasis. 2012. PMID: 22699363

10

Anti-cytotoxic T lymphocyte antigen-4 antibodies in melanoma.

Tosti G, Cocorocchio E, Pennacchioli E. Tosti G, et al. Clin Cosmet Investig Dermatol. 2013 Oct 17;6:245-56. doi: 10.2147/CCID.S24246. Clin Cosmet Investig Dermatol. 2013. PMID: 24204168 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

165 results

Search Page